Pharma Deals Review is a journal that delivers relevant analyses on deals within the pharmaceutical and biotechnology industry worldwide. It examines industry issues and their impact on the deal making environment.

The Journal analyses specific deals and reports on trends and developments within deal-making in different technology and therapy areas. It also publishes articles based on the analyses of data presented in PharmaDeals v4 Agreements database, as well as many other sources of information available to our expert team of writers.

Pharma Deals Review is read by professionals in the life sciences industry involved in business development, licensing, finance, law, marketing, and by healthcare professionals working in deal making. The journal is also of interest to researchers in academic institutions and business schools, to lawyers and investment analysts, as well as to media professionals.